ZONBONG LANDSCAPE Environmental Limited(1855.HK) Announces its Global Offering
HONG KONG, Dec 22, 2020 – (ACN Newswire) – The established service provider for landscaping and ecological restoration projects in the Three Northeast Provinces of the PRC – ZONBONG LANDSCAPE Environmental Limited (the “Company”, together with its subsidiaries, the “Group”, stock code: 1855), announces details of its Global Offering and listing on the Main Board of the Stock Exchange of Hong Kong Limited (“Hong Kong Stock Exchange”).
ZONBONG LANDSCAPE Environmental Limited plans to offer an aggregate of 68,750,000 Shares (comprising 55,000,000 new Shares and 13,750,000 Sale Shares, and subject to the Over-allotment Option) under the Global Offering, of which 6,876,000 Shares (subject to reallocation) will be offered in the Hong Kong Public Offering, and 61,874,000 Shares (comprising 48,124,000 new Shares and 13,750,000 Sale Shares, and subject to the Over-allotment Option and realloca
Harbour BioMed Completes Its Global Offering and Listing on the Hong Kong Stock Exchange
CAMBRIDGE, Mass. and SUZHOU, China, Dec. 17, 2020 /PRNewswire/ HBM Holdings Limited ( Harbour BioMed , HBM or the Company ; Stock Code: 02142.HK), a global clinical-stage biopharmaceutical company, completed its global offering (the Global Offering ) and its listing on the Main Board of the Stock Exchange of Hong Kong Limited (the Stock Exchange ). The number of offer shares under the Global Offering is a total of 138,221,000 shares at a price of HK $12.38 per share, raising HK$1,711 million (USD$221 million) in total (before exercise of the over-allotment option in connection with the Global Offering). The offering was completed on December 10
NANOBIOTIX Announces Closing of Global Offering and Full Exercise of Underwriters Option to Purchase Additional ADSs, Bringing Gross Proceeds of Global Offering to $113.3 Million
Nanobiotix s ADSs began trading on the Nasdaq Global Select Market on December 11, 2020.
Announced full exercise of underwriters option to purchase additional American Depositary Shares (ADSs), with closing expected to take place on December 18, 2020. Will add approximately $14.8 million in additional gross proceeds for total of $113.3 million in gross proceeds from the offering.
Regulatory News: NANOBIOTIX (Paris:NANO) (Euronext: NANO ISIN: FR0011341205 the
Company ), a clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced the initial closing of its previously announced initial public offering on the Nasdaq Global Select Market by way of a capital increase of 7,300,000 new ordinary shares (the
NANOBIOTIX (Paris:NANO) (Euronext: NANO – ISIN : FR0011341205 – the ‘‘
Company’’), a clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced the pricing of its initial public offering on the Nasdaq Global Select Market by way of a capital increase of 7,300,000 new ordinary shares (the “
New Shares”), consisting of a public offering of 5,445,000 ordinary shares in the form of American Depositary Shares (“
ADSs”), each representing the right to receive one ordinary share, in the United States (the “
U.S. Offering”) and a concurrent offering of 1,855,000 ordinary shares in certain jurisdictions outside of the United States to certain investors (the “
NANOBIOTIX Announces the Filing of an Amended Registration Statement, Including an Estimated Initial Public Offering Range apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.